How should iron therapy be managed in a female patient whose hemoglobin is 14 g/dL while taking ferrous sulfate 325 mg daily?

Hemoglobin of 14 g/dL: Continue Iron for 2-3 Months to Replenish Stores

With a hemoglobin of 14 g/dL (now in the normal range), continue oral ferrous sulfate 325 mg once daily for an additional 2-3 months to fully replenish iron stores, then discontinue and monitor periodically for recurrence. 1

Rationale for Continued Treatment

Your patient has achieved hemoglobin normalization, but this represents only the first treatment goal. The guidelines are clear that after normalizing hemoglobin, oral iron must be continued for 2-3 additional months to replenish depleted iron stores 1. This is critical because:

• Hemoglobin recovery occurs before iron stores are fully restored
• Premature discontinuation leads to rapid recurrence of iron deficiency
• Store repletion prevents the need for repeated treatment courses

Optimizing the Current Regimen

Since the patient is responding well, maintain the current approach but optimize absorption:

Dosing schedule:

• Continue once daily dosing (not multiple times per day) 2
• Hepcidin elevation after iron intake blocks absorption for 48 hours, making multiple daily doses ineffective and increasing side effects
• The current 325 mg ferrous sulfate tablet provides 65 mg elemental iron—ideal for once-daily therapy 3

Timing and dietary considerations:

• Take on an empty stomach when possible for maximum absorption 2
• If GI side effects occur, taking with food is acceptable (though absorption decreases)
• Consider adding 80-500 mg vitamin C to enhance absorption 2
• Avoid tea and coffee within 1 hour of iron intake (powerful absorption inhibitors) 2

Monitoring Protocol

During the 2-3 month continuation phase:

• Check hemoglobin every 4 weeks to ensure it remains stable 1
• If available, check ferritin at the end of treatment to confirm store repletion (though optimal target ferritin remains unclear in guidelines) 1

After completing therapy:

• Recheck complete blood count 3 months after stopping iron 1
• Then monitor every 3 months for the first year, then every 6 months for 2-3 years 1
• This detects recurrent iron deficiency, which may indicate ongoing blood loss or underlying pathology requiring investigation

Common Pitfalls to Avoid

Do not stop iron prematurely just because hemoglobin normalized—this is the most common error. The 2-3 month continuation period is essential for preventing rapid recurrence 1.

Do not increase to multiple daily doses thinking it will speed store repletion. This only increases side effects without improving absorption due to hepcidin-mediated blockade 2.

Do not skip follow-up monitoring after discontinuation. Recurrent anemia may signal ongoing pathology (especially GI blood loss in postmenopausal women or men) that requires investigation 1.

When to Consider IV Iron Instead

IV iron would only be indicated if:

• Hemoglobin had not increased by ≥1 g/dL within 2 weeks of starting oral therapy 2
• Ferritin failed to rise after 1 month of adherent oral therapy 2
• Intolerable GI side effects developed 2

Since your patient achieved normal hemoglobin, oral therapy is clearly working and should be continued as outlined above.